No Significant Association Found Between Androgen Deprivation Therapy and Cardiovascular Death
16 January 2012
Treatment with androgen deprivation therapy (ADT) does not significantly increase the risk of cardiovascular mortality according to evaluation of mortality data in a large registry of men treated for prostate cancer. ADT is commonly used to treat prostate cancer. Some studies have shown that it may increase the risk of cardiovascular disease, but other studies have [...]
